{
    "organizations": [],
    "uuid": "0e69808adf664ab2d872702efffa6deafef31e34",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-helius-medical-if-co-fails-to-ensu/brief-helius-medical-if-co-fails-to-ensure-commercialization-of-pons-treatment-is-available-for-u-s-government-by-dec-31-2021-co-may-forfeit-right-to-pursue-commercialization-idUSFWN1SM0O4",
    "ord_in_thread": 0,
    "title": "BRIEF-Helius Medical - If Co Fails To Ensure Commercialization Of Pons Treatment Is Available For U.S. Government By Dec. 31, 2021, Co May Forfeit Right To Pursue Commercialization",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 15 (Reuters) - Helius Medical Technologies Inc:\n* HELIUS MEDICAL TECHNOLOGIES - IF CO FAILS TO ENSURE COMMERCIALIZATION OF PONS TREATMENT IS AVAILABLE FOR U.S. GOVERNMENT BY DEC. 31, 2021, CO MAY FORFEIT RIGHT TO PURSUE COMMERCIALIZATION\n* HELIUS MEDICAL - IF CO FAILS TO OBTAIN FDA MARKETING AUTHORIZATION OF PONS DEVICE BY DEC 31, 2021 CO WILL BE IN BREACH OF CRADA IF TERMINATION DATE IS NOT EXTENDED\n* HELIUS MEDICAL- IF CO FAILS TO OBTAIN MARKETING AUTHORIZATION, ENSURE PONS DEVICE IS AVAILABLE FOR GOVERNMENT BY DEC. 31, 2021, CO MAY BE REQUIRED TO PAY $2 MILLION TO A&B\n* HELIUS MEDICAL- LOSS OF CO'S ABILITY TO EXCLUSIVELY MARKET AND SELL THE PONS TREATMENT WOULD HAVE A MATERIAL ADVERSE EFFECT ON ITS BUSINESS Source text: ( bit.ly/2jVt4ZU ) Further company coverage: (Reuters.Briefs@thomsonreuters.com)\nOur Standards: The Thomson Reuters Trust Principles. ",
    "published": "2018-05-15T19:24:00.000+03:00",
    "crawled": "2018-05-16T19:09:40.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "helius",
        "medical",
        "technology",
        "inc",
        "helius",
        "medical",
        "technology",
        "co",
        "fails",
        "ensure",
        "commercialization",
        "pons",
        "treatment",
        "available",
        "government",
        "co",
        "may",
        "forfeit",
        "right",
        "pursue",
        "commercialization",
        "helius",
        "medical",
        "co",
        "fails",
        "obtain",
        "fda",
        "marketing",
        "authorization",
        "pons",
        "device",
        "dec",
        "co",
        "breach",
        "crada",
        "termination",
        "date",
        "extended",
        "helius",
        "co",
        "fails",
        "obtain",
        "marketing",
        "authorization",
        "ensure",
        "pons",
        "device",
        "available",
        "government",
        "co",
        "may",
        "required",
        "pay",
        "million",
        "b",
        "helius",
        "loss",
        "co",
        "ability",
        "exclusively",
        "market",
        "sell",
        "pons",
        "treatment",
        "would",
        "material",
        "adverse",
        "effect",
        "business",
        "source",
        "text",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle"
    ]
}